AUTHOR=Jeong Yun-Jeong , Park Jae Seuk , Kim Hyung Woo , Min Jinsoo , Ko Yousang , Oh Jee Youn , Lee Eun Hye , Yang Bumhee , Lee Min Ki , Kim Yun Seong , Chang Jung Hyun , Jegal Yangjin , Lee Sung Soon , Kim Ju Sang , Koo Hyeon-Kyoung TITLE=Deaths from tuberculosis: differences between tuberculosis-related and non-tuberculosis-related deaths JOURNAL=Frontiers in Public Health VOLUME=11 YEAR=2023 URL=https://www.frontiersin.org/journals/public-health/articles/10.3389/fpubh.2023.1207284 DOI=10.3389/fpubh.2023.1207284 ISSN=2296-2565 ABSTRACT=Objective

Tuberculosis (TB) is a major cause of ill health and one of the leading causes of death worldwide. The first step in developing strategies to reduce TB mortality is to identify the direct causes of death in patients with TB and the risk factors for each cause.

Methods

Data on patients with TB systemically collected from the National Surveillance System of South Korea from January 2019 to December 2020 were included in this study. We analyzed the clinical characteristics associated with TB and non-TB-related deaths, including TB-related symptoms, comorbidities, and radiographic and microbiological findings.

Results

Of the total of 12,340 patients with TB, 61% were males with a mean age of 61.3 years. During the follow-up period, the overall mortality rate was 10.6%, with TB-related deaths accounting for 21.3% of all TB deaths. The median survival time in the TB-related death group was 22 days. TB-related death was associated with older age, lower body mass index (BMI), dyspnea, fever, general weakness, bilateral radiographic patterns, and acid-fast bacilli (AFB)-positive smears. Non-TB-related deaths were associated with older age, male sex, lower BMI, comorbidities of heart, liver, kidney, and central nervous system (CNS) diseases, CNS TB involvement, the presence of dyspnea, general weakness, and bilateral radiographic patterns.

Conclusion

Patients with high-risk TB must be identified through cause-specific mortality analysis, and the mortality rate must be reduced through intensive monitoring of patients with a high TB burden and comorbidities.